机构

• 上海药物研究所 [40]
• 金属研究所 [8]
• 长春光学精密机械与物... [1]
• 昆明植物研究所 [1]
• 合肥物质科学研究院 [1]

采集方式

• OAI收割 [51]

内容类型

• 期刊论文 [46]
• 会议论文 [5]

发表日期

• 2023 [1]
• 2022 [1]
• 2020 [1]
• 2019 [3]
• 2018 [2]
• 2017 [1]
• 更多

学科主题

• Biochemist... [1]
• Chemistry [1]

筛选

浏览/检索结果: 共51条，第1-10条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择题名升序题名降序提交时间升序提交时间降序作者升序作者降序发表日期升序发表日期降序 Cytostatic Activity of Sanguinarine and a Cyanide Derivative in Human Erythroleukemia Cells Is Mediated by Suppression of c-MET/MAPK Signaling 期刊论文  OAI收割 INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 卷号: 24, 期号: 9, 页码: 8113 作者:  Xu,Xinglian;  Deng,Lulu;  Tang,Yaling;  Li,Jiang;  Zhong,Ting   |  收藏  |  浏览/下载：11/0  |  提交时间：2024/05/09 leukemia  sanguinarine  c-MET  MAPK  PI3K/mTOR  STAT3  MET   The HDAC inhibitor GCJ-490A suppresses c-Met expression through IKK? and overcomes gefitinib resistance in non-small cell lung cancer 期刊论文  OAI收割 CANCER BIOLOGY & MEDICINE, 2022, 卷号: 19, 期号: 8, 页码: 1172-1192 作者:  He, Ting;  Gao, Yinglei;  Fang, Yanfen;  Zhang, Yangming;  Zhang, Shuwei   |  收藏  |  浏览/下载：27/0  |  提交时间：2024/03/21 HDAC inhibitor  c-Met  IKK?  NSCLC  gefitinib   Synthesis of triazolotriazine derivatives as c-Met inhibitors 期刊论文  OAI收割 MOLECULAR DIVERSITY, 2020, 页码: 8 作者:  Guo, Yuting;  Peng, Xia;  Ji, Yinchun;  Zhang, Yitong;  Ding, Jian   |  收藏  |  浏览/下载：47/0  |  提交时间：2020/12/24 Receptor tyrosine kinase  c-Met  Triazolotriazine  SAR  Cellular potency   SHR-A1403, a novel c-mesenchymal-epithelial transition factor (c-Met) antibody-drug conjugate, overcomes AZD9291 resistance in non-small cell lung cancer cells overexpressing c-Met 期刊论文  OAI收割 CANCER SCIENCE, 2019, 页码: 11 作者:  Tong, Mengya;  Gao, Mingzhao;  Xu, Yongping;  Fu, Li;  Li, Yun   |  收藏  |  浏览/下载：63/0  |  提交时间：2020/07/01 AZD9291  c-Met ADC  c-Met overexpression  resistance  SHR-A1403   SHR-A1403, a novel c-Met antibody-drug conjugate, exerts encouraging anti-tumor activity in c-Met-overexpressing models 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2019, 卷号: 40, 期号: 7, 页码: 971-979 作者:  Yang, Chang-yong;  Wang, Lei;  Sun, Xing;  Tang, Mi;  Quan, Hai-tian   |  收藏  |  浏览/下载：44/0  |  提交时间：2020/07/01 SHR-A1403  c-Met ADC  anti-tumor  patient-derived xenograft (PDX)  molecular mechanisms   Targeting slug-mediated non-canonical activation of c-Met to overcome chemo-resistance in metastatic ovarian cancer cells 期刊论文  OAI收割 ACTA PHARMACEUTICA SINICA B, 2019, 卷号: 9 -   |  收藏  |  浏览/下载：36/0  |  提交时间：2020/10/26 EPITHELIAL-MESENCHYMAL TRANSITION  TUMOR-GROWTH  HETEROGENEITY  AMPLIFICATION  CONTRIBUTES  PROGRESSION  CARCINOMA  REVEALS  PATHWAY  SNAIL  Slug  c-Met  Drug resistance  Ovarian cancer  XL184   Discovery, optimization and biological evaluation for novel c-Met kinase inhibitors 期刊论文  OAI收割 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 卷号: 143, 页码: 491-502 作者:  Yuan, Haoliang;  Liu, Qiufeng;  Zhang, Li;  Hu, Shihe;  Chen, Tiantian   |  收藏  |  浏览/下载：65/0  |  提交时间：2019/01/08 c-Met  Virtual screening  Pharmacophore  X-ray crystallography  Structural optimization   Pharmacologic characterization of CT-711, a novel dual inhibitor of ALK and c-Met 期刊论文  OAI收割 AMERICAN JOURNAL OF CANCER RESEARCH, 2018, 卷号: 8, 期号: 8, 页码: 1541-1550 作者:  Wang, Lei;  Gao, Mingzhao;  Tong, Mengya;  Xie, Chengying;  He, Ye   |  收藏  |  浏览/下载：154/0  |  提交时间：2019/01/08 CT-711  ALK  c-Met  crizotinib  antitumor activity  pharmacokinetics   Design, Synthesis, and Biological Evaluation of the First c-Met/HDAC Inhibitors Based on Pyridazinone Derivatives 期刊论文  OAI收割 ACS MEDICINAL CHEMISTRY LETTERS, 2017, 卷号: 8, 期号: 8, 页码: 830-834 作者:  Lu, Dong;  Yan, Juan;  Wang, Lang;  Liu, Hongchun;  Zeng, Limin   |  收藏  |  浏览/下载：58/0  |  提交时间：2019/01/08 Dual c-Met/HDAC inhibitor  hybrid  designed multiple ligand (DML)   Design, synthesis and biological evaluation of c-Met kinase inhibitors bearing 2-oxo-1,2-dihydroquinoline scaffold 期刊论文  OAI收割 BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 卷号: 26, 期号: 18, 页码: 4483-4486 作者:  Cui, Hong;  Peng, Xia;  Liu, Jian;  Ma, Chunhua;  Ji, Yinchun   |  收藏  |  浏览/下载：47/0  |  提交时间：2019/01/08 c-Met  Synthesis  Antiproliferative activity